Plasma concentrations and dosing of 2 long-acting injectable formulations of aripiprazole

Maintaining therapeutic plasma concentrations of an antipsychotic agent is essential in preventing relapse of symptoms in schizophrenia. Long-acting injectable (LAI) formulations provide extended exposure to antipsychotic therapy and have been useful in addressing treatment nonadherence. Aripiprazol...

Descripción completa

Detalles Bibliográficos
Autores principales: Salzman, Phyllis M, Raoufinia, Arash, Legacy, Susan, Such, Pedro, Eramo, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404798/
https://www.ncbi.nlm.nih.gov/pubmed/28461748
http://dx.doi.org/10.2147/NDT.S133433

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404798/
https://www.ncbi.nlm.nih.gov/pubmed/28461748
http://dx.doi.org/10.2147/NDT.S133433

Ejemplares similares